In part 3 of our discussion on patient adherence, Dermatology Times editorial adviser Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes. They review a method for developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area. Dr. Feldman is a professor of dermatology at the Wake Forest University School of Medicine, Winston-Salem, N.C.
n part 3 of our series on patient adherence, editorial advisor, Dr. Elaine Siegfried, and adherence expert, Dr. Steven Feldman talk about patient satisfaction measurements and best practices for using surveys to convey empathy as well as to improve your interactions with your patients.
There are a number of factors that influence whether a patient will adhere to a treatment regimen. In part 2 of our discussion on adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., and adherence expert, Steven Feldman, M.D., discuss physician-patient relationships as a critical component.
Leg ulcers are a common and difficult management problem for all dermatologists. Robert Kirsner, M.D., professor and vice chairman, dermatology, University of Miami Miller School of Medicine, director of the University of Miami Hospital Wound Center, elucidates the diagnosis and management of these challenging skin problems.
Although the timeline for implementation of the ICD-10 coding system has been pushed back to October 2015, all dermatologists will have to deal with this eventually. Meaningful Use regulations are also here to stay and will impact every practitioner sooner or later. Mark Kaufman, M.D., associate clinical professor in the department of dermatology at Mount Sinai Medical School in New York, explains the many vagaries of these initiatives for those of us who insist on pretending that they will never happen.
The electronic medical record (EMR) has become a fact of life for many dermatologists while others are hesitant to change the way they have practiced and have resisted switching to this form of record keeping. Daniel Siegel, M.D., discusses the ramifications of EMR adoption and outlines the path toward adoption of this technology.
The past few years have been an exciting time for those who treat psoriasis and for many patients with severe disease because of excellent new therapies for this often intractable problem. Norman Levine, M.D., talks with Alan Menter, M.D., Baylor University Medical Center, Dallas, about recent developments in the treatment of psoriasis.
Gluten and gluten-sensitive enteropathy have become hot topics among the lay public and in medical practices. John Zone, M.D., from the University of Utah, Salt Lake City, discusses how gluten sensitive enteropathy may impact many areas of dermatology.